CD274 and head and neck squamous cell carcinoma: Robbins et al. engineered NK-92 cells to express a chimeric antigen receptor targeting PD-L1 and demonstrated potent cytotoxicity against human and murine head and neck squamous cell carcinoma (HNSCC) lines in vitro.